Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients

BACKGROUND: Studies have reported a beneficial role of the addition of trastuzumab to platin-5-FU based chemotherapy in first-line advanced HER2 positive gastroesophageal adenocarcinoma (GEA). However, the effect of taxanes combined with platin-5FU + trastuzumab (PFT) is understudied. METHODS: We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Orillard, Emeline, Henriques, Julie, Vernerey, Dewi, Almotlak, Hamadi, Calcagno, Fabien, Fein, Francine, Fratté, Serge, Jary, Marine, Klajer, Elodie, Vienot, Angelique, Borg, Christophe, Kim, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948436/
https://www.ncbi.nlm.nih.gov/pubmed/35340264
http://dx.doi.org/10.3389/fonc.2022.763926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948436/
https://www.ncbi.nlm.nih.gov/pubmed/35340264
http://dx.doi.org/10.3389/fonc.2022.763926

Ejemplares similares